Primary Site >> Colorectal Cancer
Gene >> S100A9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass. PMID: 10344284 Ref: Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. PMID: 10612291 |
Ref: Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. PMID: 11721643 |
Ref: Characterization of macrophage subpopulations in colon cancer using tissue microarrays. PMID: 15842633 |
Ref: The synergistic effect of 5-aza-2'-deoxycytidine and 5-fluorouracil on drug-resistant tumors. PMID: 17690560 |
Ref: RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. PMID: 18689872 Ref: MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells. PMID: 18931530 |
Ref: Identification of S100A8 and S100A9 as serological markers for colorectal cancer. PMID: 19186948 |
Ref: Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats. PMID: 20459814 Ref: Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. PMID: 20622003 Ref: Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces. PMID: 20684568 Ref: Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma. PMID: 20812987 Ref: Identification of distinctive protein expression patterns in colorectal adenoma. PMID: 21137016 |
Ref: S100A8/A9 activate key genes and pathways in colon tumor progression. PMID: 21228116 Ref: Expression of macrophage antigens by tumor cells. PMID: 21506012 Ref: The proteomics of colorectal cancer: identification of a protein signature associated with prognosis. PMID: 22125622 |
Ref: S100A9 a new marker for monocytic human myeloid-derived suppressor cells. PMID: 22304731 Ref: Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer. PMID: 22351690 Ref: The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment. PMID: 22634002 |
Ref: Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions. PMID: 23388545 Ref: Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. PMID: 23585443 Ref: S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/beta-catenin pathway. PMID: 23637971 Ref: Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics. PMID: 23737015 Ref: Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. PMID: 23748471 |
Ref: S100A8 and S100A9 Positive Cells in Colorectal Carcinoma: Clinicopathological Analysis. PMID: 25371673 |
Ref: A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4. PMID: 24469032 Ref: Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. PMID: 25948779 Ref: Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis. PMID: 26135667 Ref: Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment. PMID: 26673090 |
Ref: Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis. PMID: 26682511 Ref: Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer. PMID: 27006653 Ref: Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer. PMID: 27182161 Ref: Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis. PMID: 27191989 Ref: [Association between serum levels of S100A8/S100A9 and clinical features of colorectal cancer patients]. PMID: 27374437 |
Ref: Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis. PMID: 27797827 Ref: [Identification of the interacting proteins with S100A8 or S100A9 by affinity purification and mass spectrometry]. PMID: 28490692 Ref: Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice. PMID: 29326691 |